2013 Q1 Form 10-Q Financial Statement

#000119312513187272 Filed on April 30, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $457.4M $601.9M
YoY Change -24.01% 16.42%
Cost Of Revenue $259.1M $318.1M
YoY Change -18.55% 10.84%
Gross Profit $198.3M $283.8M
YoY Change -30.13% 23.39%
Gross Profit Margin 43.35% 47.15%
Selling, General & Admin $87.90M $101.2M
YoY Change -13.14% 0.3%
% of Gross Profit 44.33% 35.66%
Research & Development $29.00M $27.90M
YoY Change 3.94% -7.92%
% of Gross Profit 14.62% 9.83%
Depreciation & Amortization $24.70M $24.60M
YoY Change 0.41% -61.38%
% of Gross Profit 12.46% 8.67%
Operating Expenses $116.9M $129.1M
YoY Change -9.45% -1.6%
Operating Profit $81.40M $154.7M
YoY Change -47.38% 56.58%
Interest Expense -$35.80M -$39.20M
YoY Change -8.67% -18.33%
% of Operating Profit -43.98% -25.34%
Other Income/Expense, Net -$3.100M -$30.80M
YoY Change -89.94% -851.22%
Pretax Income $44.40M $83.20M
YoY Change -46.63% 51.55%
Income Tax $16.90M $25.20M
% Of Pretax Income 38.06% 30.29%
Net Earnings $27.50M $58.00M
YoY Change -52.59% 57.18%
Net Earnings / Revenue 6.01% 9.64%
Basic Earnings Per Share $0.15 $0.32
Diluted Earnings Per Share $0.15 $0.31
COMMON SHARES
Basic Shares Outstanding 184.7M shares 181.4M shares
Diluted Shares Outstanding 187.8M shares 186.2M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.9M $192.9M
YoY Change -37.33%
Cash & Equivalents $120.9M $192.9M
Short-Term Investments
Other Short-Term Assets $28.90M $44.00M
YoY Change -34.32%
Inventory $168.2M $171.5M
Prepaid Expenses
Receivables $204.0M $240.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $578.7M $648.8M
YoY Change -10.8%
LONG-TERM ASSETS
Property, Plant & Equipment $585.2M $591.7M
YoY Change -1.1%
Goodwill $1.941B
YoY Change
Intangibles $1.686B
YoY Change
Long-Term Investments
YoY Change
Other Assets $91.60M $98.00M
YoY Change -6.53%
Total Long-Term Assets $4.325B $4.459B
YoY Change -3.01%
TOTAL ASSETS
Total Short-Term Assets $578.7M $648.8M
Total Long-Term Assets $4.325B $4.459B
Total Assets $4.904B $5.108B
YoY Change -4.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $161.4M $213.0M
YoY Change -24.23%
Accrued Expenses $83.60M $93.00M
YoY Change -10.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $23.50M $8.000M
YoY Change 193.75%
Total Short-Term Liabilities $396.8M $451.0M
YoY Change -12.02%
LONG-TERM LIABILITIES
Long-Term Debt $2.791B $3.166B
YoY Change -11.83%
Other Long-Term Liabilities $208.6M $367.7M
YoY Change -43.27%
Total Long-Term Liabilities $3.000B $3.534B
YoY Change -15.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $396.8M $451.0M
Total Long-Term Liabilities $3.000B $3.534B
Total Liabilities $3.509B $4.220B
YoY Change -16.84%
SHAREHOLDERS EQUITY
Retained Earnings -$185.9M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.0K
YoY Change
Treasury Stock Shares
Shareholders Equity $1.395B $888.3M
YoY Change
Total Liabilities & Shareholders Equity $4.904B $5.108B
YoY Change -4.0%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $27.50M $58.00M
YoY Change -52.59% 57.18%
Depreciation, Depletion And Amortization $24.70M $24.60M
YoY Change 0.41% -61.38%
Cash From Operating Activities $54.70M $139.6M
YoY Change -60.82% 27.02%
INVESTING ACTIVITIES
Capital Expenditures $12.60M $35.70M
YoY Change -64.71% -407.76%
Acquisitions
YoY Change
Other Investing Activities -$200.0K $300.0K
YoY Change -166.67% -94.83%
Cash From Investing Activities -$19.10M -$35.40M
YoY Change -46.05% 510.34%
FINANCING ACTIVITIES
Cash Dividend Paid $11.10M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.100M -217.8M
YoY Change -100.96%
NET CHANGE
Cash From Operating Activities 54.70M 139.6M
Cash From Investing Activities -19.10M -35.40M
Cash From Financing Activities 2.100M -217.8M
Net Change In Cash 37.70M -113.6M
YoY Change -133.19% -209.13%
FREE CASH FLOW
Cash From Operating Activities $54.70M $139.6M
Capital Expenditures $12.60M $35.70M
Free Cash Flow $42.10M $103.9M
YoY Change -59.48% -14.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
115400000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
314000000
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
60700000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1356900000
CY2012Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
200000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11300000
CY2012Q4 us-gaap Goodwill
Goodwill
1941000000
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2012Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3657100000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55300000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
167400000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32700000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7500000
CY2012Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
36200000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90100000
CY2012Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
5000000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47500000
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
34600000
CY2012Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
80600000
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
109700000
CY2012Q4 us-gaap Liabilities
Liabilities
3509100000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
133100000
CY2012Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
44500000
CY2012Q4 us-gaap Notional Amount Of Interest Rate Derivatives
NotionalAmountOfInterestRateDerivatives
1375000000
CY2012Q4 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
870000000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21600000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
213800000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Derivative Assets
DerivativeAssets
200000
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
80200000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32300000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202300000
CY2012Q4 us-gaap Assets
Assets
4866000000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
100000
CY2012Q4 us-gaap Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent
DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent
200000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165000000
CY2012Q4 us-gaap Inventory Net
InventoryNet
157100000
CY2012Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
75200000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4866000000
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-200000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
2801300000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
200000
CY2012Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
73500000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80200000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1716100000
CY2012Q4 us-gaap Derivative Financial Instruments Liabilities Fair Value Disclosure
DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure
52900000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43900000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
377800000
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
63500000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
900000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24500000
CY2012Q4 us-gaap Interest Rate Derivatives At Fair Value Net
InterestRateDerivativesAtFairValueNet
-52300000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14200000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
42600000
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6900000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
834900000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
490300000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
596200000
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19500000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1601500000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2801300000
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
6100000
CY2012Q4 alsn Assets And Liabilities Fair Value Disclosure
AssetsAndLiabilitiesFairValueDisclosure
33600000
CY2012Q4 alsn Amount Of Collateral Recorded In Other Current Assets
AmountOfCollateralRecordedInOtherCurrentAssets
3000000
CY2012Q4 alsn Assets Held In Trusts
AssetsHeldInTrusts
200000
CY2012Q4 alsn Long Term Debt Current And Non Current
LongTermDebtCurrentAndNonCurrent
2820800000
CY2012Q4 alsn Sales Allowances
SalesAllowances
27000000
CY2012Q4 alsn Vendor Buyback Obligation
VendorBuybackObligation
13900000
CY2012Q4 alsn Intangible Assets Excluding Goodwill Gross
IntangibleAssetsExcludingGoodwillGross
2551000000
CY2012Q4 alsn Defense Price Reduction Reserve
DefensePriceReductionReserve
12000000
CY2012Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
32100000
CY2012Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113600000
CY2012Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
81500000
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192900000
CY2012Q1 us-gaap Deferred Revenue
DeferredRevenue
61200000
CY2012Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
41500000
CY2013Q1 us-gaap Goodwill
Goodwill
1941000000
CY2013Q1 us-gaap Notes Payable Current
NotesPayableCurrent
CY2013Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3627200000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
56700000
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
154500000
CY2013Q1 us-gaap Other Assets Current
OtherAssetsCurrent
28900000
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9800000
CY2013Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
35900000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91600000
CY2013Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
5000000
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
92400000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
1394800000
CY2013Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
800000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
43800000
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9200000
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
87200000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23800000
CY2013Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2866700000
CY2013Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
34300000
CY2013Q1 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
91200000
CY2013Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
107500000
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
275500000
CY2013Q1 us-gaap Liabilities
Liabilities
3509100000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
161400000
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
98800000
CY2013Q1 us-gaap Notional Amount Of Interest Rate Derivatives
NotionalAmountOfInterestRateDerivatives
1375000000
CY2013Q1 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
870000000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21500000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
208600000
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Sales Revenue Goods Net Percentage
SalesRevenueGoodsNetPercentage
0.78 pure
CY2013Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
120900000
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
21200000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185900000
CY2013Q1 us-gaap Assets
Assets
4903900000
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
100000
CY2013Q1 us-gaap Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent
DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent
700000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
204000000
CY2013Q1 us-gaap Inventory Net
InventoryNet
168200000
CY2013Q1 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
115900000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4903900000
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-1500000
CY2013Q1 us-gaap Long Term Debt
LongTermDebt
2791400000
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
200000
CY2013Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
71600000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120900000
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1686200000
CY2013Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
800000
CY2013Q1 us-gaap Derivative Financial Instruments Liabilities Fair Value Disclosure
DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure
45400000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-46500000
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
89700000
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
97100000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
396800000
CY2013Q1 alsn Amount Of Collateral Recorded In Other Current Assets
AmountOfCollateralRecordedInOtherCurrentAssets
3400000
CY2013Q1 alsn Assets Held In Trusts
AssetsHeldInTrusts
700000
CY2013Q1 alsn Long Term Debt Current And Non Current
LongTermDebtCurrentAndNonCurrent
2814900000
CY2013Q1 alsn Research And Development Payable
ResearchAndDevelopmentPayable
3100000
CY2013Q1 alsn Sales Allowances
SalesAllowances
26200000
CY2013Q1 us-gaap Deferred Revenue
DeferredRevenue
61600000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1200000
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23400000
CY2013Q1 us-gaap Interest Rate Derivatives At Fair Value Net
InterestRateDerivativesAtFairValueNet
-43100000
CY2013Q1 us-gaap Interest Payable Current
InterestPayableCurrent
24400000
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40600000
CY2013Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
8300000
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
864800000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
578700000
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
585200000
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
23500000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1625500000
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2791400000
CY2013Q1 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
10200000
CY2013Q1 alsn Assets And Liabilities Fair Value Disclosure
AssetsAndLiabilitiesFairValueDisclosure
85700000
CY2013Q1 alsn Number Of Employees
NumberOfEmployees
2800 Employee
CY2013Q1 alsn Achieved Senior Secured Leverage Ratio
AchievedSeniorSecuredLeverageRatio
3.57 pure
CY2013Q1 alsn Vendor Buyback Obligation
VendorBuybackObligation
13000000
CY2013Q1 alsn Ownership Percentage By Related Parties
OwnershipPercentageByRelatedParties
0.813 pure
CY2013Q1 alsn Intangible Assets Excluding Goodwill Gross
IntangibleAssetsExcludingGoodwillGross
2551000000
CY2013Q1 alsn Defense Price Reduction Reserve
DefensePriceReductionReserve
12200000
CY2013Q1 alsn Achieved Total Leverage Ratio
AchievedTotalLeverageRatio
4.33 pure
alsn Grant Program Income
GrantProgramIncome
42000000
CY2011 alsn Percentage Of Annual Excess Cash Flow For Pre Payment Of Loan
PercentageOfAnnualExcessCashFlowForPrePaymentOfLoan
0.00 pure
CY2012 alsn Percentage Of Annual Excess Cash Flow For Pre Payment Of Loan
PercentageOfAnnualExcessCashFlowForPrePaymentOfLoan
0.50 pure
CY2013Q1 dei Trading Symbol
TradingSymbol
ALSN
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
ALLISON TRANSMISSION HOLDINGS INC
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001411207
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
457400000
CY2013Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
5900000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28600000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3400000
CY2013Q1 us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
6300000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
81400000
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100000
CY2013Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2000000
CY2013Q1 us-gaap Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount
MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount
2500000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24900000
CY2013Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
16100000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000
CY2013Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9900000
CY2013Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-600000
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3100000 shares
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.381 pure
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40300000
CY2013Q1 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
16900000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15800000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
54700000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19100000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
200000
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1200000
CY2013Q1 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
1600000
CY2013Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
6700000
CY2013Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
3300000
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2900000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12600000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
40700000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
187800000 shares
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2600000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2013Q1 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE A.&#xA0;OVERVIEW</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Overview</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Allison Transmission Holdings, Inc. and its subsidiaries (the &#x201C;Company&#x201D; or &#x201C;Allison&#x201D;), design and manufacture commercial and defense fully-automatic transmissions.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The business was founded in 1915 and has been headquartered in Indianapolis, Indiana since inception. The Company has approximately 2,800 employees and 12 different transmission product lines. Although approximately 78% of revenues were generated in North America in 2012, the Company has a global presence by serving customers in Europe, Asia, South America and Africa. The Company serves customers through an independent network of approximately 1,400 independent distributor and dealer locations worldwide.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Since the introduction of the Company&#x2019;s first fully-automatic transmission over 60 years ago, the Company&#x2019;s products have gained acceptance in a wide variety of applications, including on-highway trucks (distribution, refuse, construction, fire and emergency), buses (primarily school, transit and hybrid-transit), motorhomes, off-highway vehicles and equipment (primarily energy, mining and construction) and defense vehicles (wheeled and tracked). The Company has developed over 100 different product models that are used in more than 2,500 different vehicle configurations, which are compatible with more than 500 combinations of engine brands, models and ratings. The Company also sells support equipment and Allison-branded replacement parts for the Company&#x2019;s transmissions and remanufactured transmissions for use in the vehicle aftermarket.</font></p> </div>
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29000000
CY2013Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5500000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2100000
CY2013Q1 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
2500000
CY2013Q1 us-gaap Increase Decrease In Collateral Held Under Securities Lending
IncreaseDecreaseInCollateralHeldUnderSecuritiesLending
400000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4900000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184700000 shares
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12200000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
259100000
CY2013Q1 us-gaap Depreciation
Depreciation
24700000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44400000
CY2013Q1 us-gaap Gross Profit
GrossProfit
198300000
CY2013Q1 us-gaap Interest Paid
InterestPaid
30000000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16100000
CY2013Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2500000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
27500000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3100000
CY2013Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-1900000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4900000
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
600000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87900000
CY2013Q1 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
5200000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16900000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3000000
CY2013Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Significant estimates include, but are not limited to, allowance for doubtful accounts, sales allowances, government price adjustments, fair market values and future cash flows associated with goodwill, indefinite life intangibles, long-lived asset impairment tests, useful lives for depreciation and amortization, warranty liability, determination of discount and other assumptions for pension and other postretirement benefit expense, income taxes and deferred tax valuation allowances, derivative valuation, and contingencies. The Company&#x2019;s accounting policies involve the application of judgments and assumptions made by management that include inherent risks and uncertainties. Actual results could differ materially from these estimates. Changes in estimates are recorded in results of operations in the period that the events or circumstances giving rise to such changes occur.</font></font></p> </div>
CY2013Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
11100000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29900000
CY2013Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
7300000
CY2013Q1 alsn Assets In Service Under Grant Program
AssetsInServiceUnderGrantProgram
7100000
CY2013Q1 alsn Combinations Of Engine Brands Models And Ratings
CombinationsOfEngineBrandsModelsAndRatings
500 Brand
CY2013Q1 alsn Depreciation Related To Grant Program
DepreciationRelatedToGrantProgram
100000
CY2013Q1 alsn Different Product Models
DifferentProductModels
100 Product
CY2013Q1 alsn Different Vehicle Configurations
DifferentVehicleConfigurations
2500 Vehicle
CY2013Q1 alsn Grant Program Income
GrantProgramIncome
1200000
CY2013Q1 alsn Independent Distributor And Dealer In Worldwide Locations
IndependentDistributorAndDealerInWorldwideLocations
1400 Customer
CY2013Q1 alsn Interest Expenses
InterestExpenses
34100000
CY2013Q1 alsn Reduction Of Basis Of Capital Assets Purchased Under Grant Program
ReductionOfBasisOfCapitalAssetsPurchasedUnderGrantProgram
1400000
CY2013Q1 alsn Transmission Product Lines
TransmissionProductLines
12 Product
CY2013Q1 alsn Year Of Introduction Of Company Automatic Products
YearOfIntroductionOfCompanyAutomaticProducts
P60Y
CY2013Q1 alsn Accretion For Predecessor Liability
AccretionForPredecessorLiability
200000
CY2013Q1 alsn Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
400000
CY2013Q1 alsn Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-2200000
CY2012Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13500000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
154700000
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-200000
CY2012Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-200000
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
601900000
CY2012Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4500000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1700000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000
CY2012Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8900000
CY2012Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
100000
CY2012Q1 us-gaap Early Repayment Of Subordinated Debt
EarlyRepaymentOfSubordinatedDebt
211000000
CY2012Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4800000 shares
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.303 pure
CY2012Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
2000000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
50200000
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
64800000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139600000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35400000
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
300000
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2900000
CY2012Q1 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
2300000
CY2012Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
5300000
CY2012Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
5500000
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2400000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35700000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-121100000
CY2012Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2500000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186200000 shares
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
44900000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27900000
CY2012Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7100000
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-217800000
CY2012Q1 us-gaap Increase Decrease In Collateral Held Under Securities Lending
IncreaseDecreaseInCollateralHeldUnderSecuritiesLending
-100000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181400000 shares
CY2012Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-16000000
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14900000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
318100000
CY2012Q1 us-gaap Depreciation
Depreciation
24600000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
83200000
CY2012Q1 us-gaap Gross Profit
GrossProfit
283800000
CY2012Q1 us-gaap Interest Paid
InterestPaid
36100000
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21000000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
58000000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30800000
CY2012Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
700000
CY2012Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
700000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101200000
CY2012Q1 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
5000000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25200000
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7500000
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37500000
CY2012Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5200000
CY2012Q1 alsn Depreciation Related To Grant Program
DepreciationRelatedToGrantProgram
100000
CY2012Q1 alsn Grant Program Income
GrantProgramIncome
2800000
CY2012Q1 alsn Initial Public Offering Fees And Expenses
InitialPublicOfferingFeesAndExpenses
5700000
CY2012Q1 alsn Interest Expenses
InterestExpenses
41000000
CY2012Q1 alsn Reduction Of Basis Of Capital Assets Purchased Under Grant Program
ReductionOfBasisOfCapitalAssetsPurchasedUnderGrantProgram
1500000
CY2012Q1 alsn Accretion For Predecessor Liability
AccretionForPredecessorLiability
200000
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06

Files In Submission

Name View Source Status
0001193125-13-187272-index-headers.html Edgar Link pending
0001193125-13-187272-index.html Edgar Link pending
0001193125-13-187272.txt Edgar Link pending
0001193125-13-187272-xbrl.zip Edgar Link pending
alsn-20130331.xml Edgar Link completed
alsn-20130331.xsd Edgar Link pending
alsn-20130331_cal.xml Edgar Link unprocessable
alsn-20130331_def.xml Edgar Link unprocessable
alsn-20130331_lab.xml Edgar Link unprocessable
alsn-20130331_pre.xml Edgar Link unprocessable
d503400d10q.htm Edgar Link pending
d503400dex311.htm Edgar Link pending
d503400dex312.htm Edgar Link pending
d503400dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g503400g98z45.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending